Genomic Applications Partnership Program — National (N-GAPP)

N-GAPP — National Genomic Partnership Program

Funds public-private genomics R&D projects up to CAD 2 million in which Canadian academic researchers partner with for-profit industry receptors to apply genomics outcomes to commercial needs.

⚠ This may reflect a past cycle — verify the current call on the funder's site.

Genome Canada, the federally supported not-for-profit that invests in genomics science and its applications across Canada, operates the Genomic Applications Partnership Program (GAPP) as its flagship commercialization instrument. The National stream (N-GAPP) pairs genomics researchers with non-academic end-users — industry companies, government agencies, or non-profit organisations — to apply genomic science to a defined real-world challenge. The programme draws on a total investment of $90 million CAD across four funding cycles, which sits within a broader $175.1 million CAD commitment over seven years through the Canadian Genomics Strategy for commercialization, data coordination, and talent development.

For the 2026 N-GAPP cycle, Genome Canada contributes between $300,000 and $2,000,000 CAD per project, capped at one-third of the total project budget; the remaining two-thirds must come from other sources including the end-user partner. The total project envelope therefore ranges from $900,000 to $6,000,000 CAD. Projects run for a maximum of two years, with a target start date of 1 January 2027. Key deadlines for the 2026 cycle are: letters of intent due 22 April 2026, draft full proposals due 21 May 2026, and signed full proposals due 22 June 2026. Applications must be submitted through one of six regional Genome Centres — Genome BC, Genome Prairie, Genome Alberta, Ontario Genomics, Genome Québec, or Genome Atlantic — as Genome Canada does not accept proposals directly.

Eligible applicants span academia, industry, research organisations, and non-profits, provided the team includes a non-academic end-user as a core partner. Applications may be submitted in English or French. Organisations new to the programme should engage their regional Genome Centre early, as the Centres provide coaching on proposal development, help identify co-funding partners, and manage the regional review step before proposals advance to Genome Canada's national evaluation.